Goldman Sachs’s Lifecore Biomedical LFCR Stock Holding History

Goldman Sachs’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$626K	Buy	168,376 +74,725	+80%	+$516K	﹤0.01%	5450
2025 Q4	$766K	Buy	93,651 +38,315	+69%	+$283K	﹤0.01%	5315
2025 Q3	$407K	Buy	55,336 +14,997	+37%	+$113K	﹤0.01%	5615
2025 Q2	$328K	Sell	40,339 -47,659	-54%	-$321K	﹤0.01%	5390
2025 Q1	$620K	Buy	87,998 +12,647	+17%	+$78.6K	﹤0.01%	5054
2024 Q4	$560K	Buy	75,351 +16,437	+28%	+$105K	﹤0.01%	5187
2024 Q3	$290K	Buy	58,914 +20,038	+52%	+$105K	﹤0.01%	5309
2024 Q2	$199K	Sell	38,876 -48,825	-56%	-$289K	﹤0.01%	5270
2024 Q1	$466K	Buy	87,701 +54,106	+161%	+$387K	﹤0.01%	4785
2023 Q4	$208K	Buy	33,595 +22,558	+204%	+$157K	﹤0.01%	5139
2023 Q3	$83.3K	Sell	11,037 -34,199	-76%	-$313K	﹤0.01%	5214
2023 Q2	$437K	Sell	45,236 -29,564	-40%	-$181K	﹤0.01%	4810
2023 Q1	$282K	Buy	74,800 +6,422	+9%	+$35.8K	﹤0.01%	5142
2022 Q4	$443K	Sell	68,378 -13,539	-17%	-$112K	﹤0.01%	4939
2022 Q3	$728K	Buy	81,917 +3,139	+4%	+$31.9K	﹤0.01%	4726
2022 Q2	$785K	Sell	78,778 -9,288	-11%	-$92K	﹤0.01%	4793
2022 Q1	$1.02M	Sell	88,066 -9,709	-10%	-$108K	﹤0.01%	4799
2021 Q4	$1.08M	Buy	97,775 +61,148	+167%	+$593K	﹤0.01%	4772
2021 Q3	$338K	Sell	36,627 -56,102	-61%	-$610K	﹤0.01%	5425
2021 Q2	$1.04M	Sell	92,729 -51,706	-36%	-$596K	﹤0.01%	4723
2021 Q1	$1.53M	Sell	144,435 -103,150	-42%	-$1.16M	﹤0.01%	4255
2020 Q4	$2.69M	Buy	247,585 +39,528	+19%	+$408K	﹤0.01%	3500
2020 Q3	$2.02M	Buy	208,057 +8,219	+4%	+$78.3K	﹤0.01%	3554
2020 Q2	$1.59M	Buy	199,838 +80,705	+68%	+$833K	﹤0.01%	3614
2020 Q1	$1.03M	Buy	119,133 +3,794	+3%	+$39.5K	﹤0.01%	3728
2019 Q4	$1.3M	Buy	115,339 +48,864	+74%	+$520K	﹤0.01%	3951
2019 Q3	$722K	Buy	66,475 +29,584	+80%	+$322K	﹤0.01%	4245
2019 Q2	$346K	Sell	36,891 -11,025	-23%	-$111K	﹤0.01%	4556
2019 Q1	$588K	Sell	47,916 -14,438	-23%	-$176K	﹤0.01%	4340
2018 Q4	$738K	Buy	62,354 +4,889	+9%	+$67.1K	﹤0.01%	4152
2018 Q3	$827K	Buy	57,465 +26,982	+89%	+$373K	﹤0.01%	4157
2018 Q2	$454K	Sell	30,483 -23,272	-43%	-$323K	﹤0.01%	4564
2018 Q1	$702K	Sell	53,755 -3,104	-5%	-$40.8K	﹤0.01%	4273
2017 Q4	$716K	Sell	56,859 -361	-0.6%	-$4.56K	﹤0.01%	4552
2017 Q3	$741K	Buy	57,220 +4,561	+9%	+$60.1K	﹤0.01%	4816
2017 Q2	$782K	Buy	52,659 +4,594	+10%	+$64K	﹤0.01%	4690
2017 Q1	$577K	Buy	48,065 +2,311	+5%	+$29.3K	﹤0.01%	4874
2016 Q4	$631K	Buy	45,754 +4,717	+11%	+$65.4K	﹤0.01%	4855
2016 Q3	$550K	Buy	41,037 +21,358	+109%	+$259K	﹤0.01%	4949
2016 Q2	$212K	Buy	19,679 +407	+2%	+$4.49K	﹤0.01%	5652
2016 Q1	$202K	Sell	19,272 -1,352	-7%	-$14.8K	﹤0.01%	5613
2015 Q4	$244K	Sell	20,624 -2,093	-9%	-$25.7K	﹤0.01%	5536
2015 Q3	$265K	Buy	22,717 +7,940	+54%	+$105K	﹤0.01%	5722
2015 Q2	$213K	Sell	14,777 -6,388	-30%	-$92.2K	﹤0.01%	6092
2015 Q1	$295K	Sell	21,165 -4,258	-17%	-$58.8K	﹤0.01%	5659
2014 Q4	$351K	Sell	25,423 -3,050	-11%	-$39.4K	﹤0.01%	5621
2014 Q3	$349K	Buy	28,473 +1,264	+5%	+$15.8K	﹤0.01%	5612
2014 Q2	$340K	Sell	27,209 -3,900	-13%	-$45.9K	﹤0.01%	5684
2014 Q1	$347K	Sell	31,109 -33,953	-52%	-$372K	﹤0.01%	5612
2013 Q4	$789K	Buy	65,062 +11,846	+22%	+$141K	﹤0.01%	4943
2013 Q3	$649K	Sell	53,216 -3,381	-6%	-$47.2K	﹤0.01%	4948
2013 Q2	$748K	Buy	+56,597	New	+$783K	﹤0.01%	4616

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return